Anemia and heart failure in chronic kidney disease

Seminars in Nephrology

Volumn 25, Issue 6, 2005, Pages 392-396

  Locatelli, Francesco ^a   Pozzoni, Pietro ^a   Del Vecchio, Lucia ^a  

^a A MANZONI HOSPITAL   (Italy)

Author keywords

Anemia; Chronic renal failure; Congestive heart failure; Left ventricular hypertrophy

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIALYSIS; EPIDEMIOLOGICAL DATA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURVIVAL RATE;

EID: 27844447731     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2005.05.008     Document Type: Article

References (33)

1. US Renal Data System USRDS 2003 Annual Data Report 2003 National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
2. H.C. Rayner, R.L. Pisoni, J. Bommer Mortality and hospitalization in haemodialysis patients in five European countries Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 19 2004 108 120
3. R.N. Foley, P.S. Parfrey, J.D. Harnett Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1995 186 192
4. US Renal Data System 2002 Annual Data Report 2002 The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
5. F. Locatelli, D. Marcelli, F. Conte Patient selection affects end-stage renal disease outcome comparisons Kidney Int 57 suppl 74 2000 94 99
6. F. Locatelli, F.K. Port, R.L. Pisoni Patient and treatment characteristics in the MPO Study validation against the DOPPS population Nephrol Dial Transplant 18 suppl 4 2003 A196
7. A. Levin, C.R. Thompson, J. Ethier Left ventricular mass index increase in early renal disease Impact of decline in hemoglobin Am J Kidney Dis 34 1999 125 134
8. D.C. Holland, M. Lam Predictors of hospitalization and death among pre-dialysis patients A retrospective cohort study Nephrol Dial Transplant 15 2000 650 658
9. B.C. Astor, P. Muntner, A. Levin Association of kidney function with anemia The Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 2002 1401 1408
10. National Kidney Foundation K/DOQI clinical practice guidelines. 2000 update Am J Kidney Dis 37 suppl 1 2001 S1 S238
11. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure Nephrol Dial Transplant 19 suppl 2 2004 1 47
12. G.T. Obrador, R. Ruthazer, P. Arora Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States J Am Soc Nephrol 10 1999 1793 1800
13. R.L. Pisoni, J.L. Bragg-Gresham, E.W. Young Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 44 2004 94 111
14. K.U. Eckardt, N. Clyne, T. Drueke Left ventricular hypertrophy and associated variables in the 'Cardiovascular Risk Reduction by Early Anemia Treatment with Epoetin beta' (CREATE) Trial Nephrol Dial Transplant 18 suppl 4 2003 A155
15. G.M. London, F. Fabiani, S.J. Marchais Uremic cardiomyopathy An inadequate left ventricular hypertrophy Kidney Int 31 1987 973 980
16. A. Levin, J. Singer, C.R. Thompson Prevalent left ventricular hypertrophy in the predialysis population Identifying opportunities for intervention Am J Kidney Dis 27 1996 347 354
17. R.N. Foley, P.S. Parfrey, J.D. Harnett The impact of anaemia on cardiomyopathy, morbidity and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
18. A.G. Stack, R. Saran Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States Am J Kidney Dis 40 2002 1202 1210
19. C.T. Jurkovitz, J.L. Abramson, L. Viola Vaccarino Association of high serum creatinine and anemia increases the risk of coronary events Results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) Study J Am Soc Nephrol 14 2003 2919 2925
20. F. Locatelli, F. Conte, D. Marcelli The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry Nephrol Dial Transplant 13 1998 1642 1644
21. J.Z. Ma, J. Ebben, H. Xia Haematocrit level and associated mortality in haemodialysis patients J Am Soc Nephrol 10 1999 610 619
22. H. Xia, J. Ebben, J.Z. Ma Haematocrit level and hospitalizations risks in haemodialysis patients J Am Soc Nephrol 10 1999 1309 1316
23. A.J. Collins, S. Li, W. St Peter Death, hospitalization and economic associations among incident hemodialysis patients with hematocrit values of 36-39% J Am Soc Nephrol 12 2001 2465 2473
24. F. Locatelli, R.L. Pisoni, C. Combe Anemia in haemodialysis patients of five European Countries Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 19 2004 121 132
25. J. Portoles, A. Torralbo, P. Martin Cardiovascular effects of recombinant human erythropoietin in predialysis patients Am J Kidney Dis 29 1997 541 548
26. T. Hayashi, A. Suzuki, T. Shoji Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure Am J Kidney Dis 35 2000 250 256
27. D.S. Silverberg, D. Wexler, M. Blum The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron Nephrol Dial Transplant 18 2003 141 146
28. H. Frank, K. Heusser, B. Hoffken Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients Kidney Int 66 2004 832 840
29. A. Besarab, W.K. Bolton, J.K. Browne The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 1998 584 590
30. R.N. Foley, P.S. Parfrey, J. Morgan Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy Kidney Int 58 2000 1325 1335
31. S.D. Roger, L.P. McMahon, A. Clarkson Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4) Results of a randomized clinical trial J Am Soc Nephrol 15 2004 148 156
32. I.C. Macdougall CREATE New strategies for early anaemia management in renal insufficiency Nephrol Dial Transplant 18 suppl 2 2003 ii13 ii16
33. M. Laville Anaemia CORrection in Diabetes trial: New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial Acta Diabetol 41 suppl 1 2004 S18 S22